New Mechanism Links RNA Structures to Parkinson’s Disease
Researchers uncover that G-quadruplex RNA structures promote α-synuclein aggregation, linked to Parkinson’s disease.
Complete the form below to unlock access to ALL audio articles.
Summary
A study from Kumamoto University reveals that G-quadruplex RNA structures facilitate the aggregation of α-synuclein, a protein involved in neurodegenerative diseases like Parkinson's. By blocking G4 formation with 5-aminolevulinic acid, researchers prevented α-synuclein aggregation and motor symptoms in mice, presenting a potential new therapeutic strategy.
Key Takeaways
A team of researchers at Kumamoto University has uncovered a groundbreaking mechanism in the formation of harmful protein aggregates that lead to neurodegenerative diseases such as Parkinson's Disease. The team, led by Professor Norifumi Shioda and Associate Professor Yasushi Yabuki, identified for the first time that unique RNA structures called G-quadruplexes (G4s) play a central role in promoting the aggregation of α-synuclein, a protein associated with neurodegeneration. By demonstrating that inhibiting G4 assembly could potentially prevent the onset of synucleinopathies, this discovery positions G4 as a promising target for early intervention in these diseases.
In a healthy state, α-synuclein typically regulates neuronal function. However, in neurodegenerative diseases, it aggregates together, leading to cell damage and motor symptoms. The researchers identified that G4s, four-stranded RNA structures that form in response to cellular stress, function as a "scaffold" that facilitates α-synuclein aggregation. Elevated calcium levels, often seen under stress, trigger G4 assembly, which then attracts α-synuclein, converting it into a harmful, aggregate-prone state.
Want more breaking news?
Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.
Subscribe for FREEThis breakthrough could significantly advance treatments aimed at neurodegenerative diseases by focusing on G4 regulation. Since G4s are also implicated in other diseases such as Alzheimer’s Disease, this discovery may broaden the impact of such treatments beyond Parkinson’s Disease. These findings were published in the journal Cell on October 18, 2024, shedding new light on preemptive strategies to combat neurodegeneration and improve quality of life for aging populations.
Reference: Matsuo K, Asamitsu S, Maeda K, et al. RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation. Cell. 2024:S0092867424011346. doi: 10.1016/j.cell.2024.09.037
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.
This content includes text that has been generated with the assistance of AI. Technology Networks' AI policy can be found here.
